Diagnostic Accuracy of Oral Images, OPGs, Biomarkers and Questionnaires vs. Clinical Assessment for Periodontal Disease (PostNCT07164573)

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Periodontal Disease; Gingivitis; Periodontitis Sponsors: Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University; University of Chieti; King’s College London; University of Roma La Sapienza; University of Turin, Italy Not...

Quality Assessment of Anterior Composite Restorations

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Composite Resins Interventions: Other: Smartphone Photography Sponsors: Recep Tayyip Erdogan University Training and Research Hospital Completed Conditions: Composite Resins Interventions: Other: Smartphone Photography Sponsors: Recep Tayyip Erdogan...

Reversal of Spinal Anesthesia Residual Motor Block Via Intrathecal Catheter

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Joint Replacement Surgery Interventions: Drug: Normal Saline 10 mL Injection Sponsors: Beth Israel Deaconess Medical Center Recruiting Conditions: Joint Replacement Surgery Interventions: Drug: Normal Saline 10 mL Injection Sponsors: Beth Israel...

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Pneumonia, Bacterial Interventions: Biological: Pn-MAPS30plus; Combination Product: PCV20 Sponsors: GlaxoSmithKline Not yet recruiting Conditions: Pneumonia, Bacterial Interventions: Biological: Pn-MAPS30plus; Combination Product: PCV20 Sponsors:...

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride (normal saline) Sponsors: siRNAgen Therapeutics Inc. Recruiting Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride...